サンプル依頼リスト カート
  • English
  • Korean
表紙：塞栓療法の世界市場規模調査＆予測、製品別、施術別、疾患適応症別、エンドユーザー別、地域別分析、2022-2029年
市場調査レポート
商品コード
1279054

塞栓療法の世界市場規模調査＆予測、製品別、施術別、疾患適応症別、エンドユーザー別、地域別分析、2022-2029年

Global Embolotherapy Market Size study & Forecast, by Product by Procedure, by Disease indication, by End user and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
塞栓療法の世界市場規模調査＆予測、製品別、施術別、疾患適応症別、エンドユーザー別、地域別分析、2022-2029年
出版日: 2023年05月09日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

塞栓療法は、様々な病状を治療するために、塞栓剤を使用して血管や血流を遮断する低侵襲な医療処置です。

塞栓剤は、固体粒子、ゲル、または液体で、血管に直接注入され、血管を凝固させ、身体の特定の部位に血液が流れるのを妨げます。塞栓療法は、子宮筋腫、肝腫瘍、動脈瘤、血管奇形など、さまざまな疾患の治療に使用されます。この技術は従来の手術よりも低侵襲で、場合によっては外来で行うことができ、回復に要する時間も短く、合併症も少ないとされています。市場成長の主な要因は、低侵襲手術の需要の高まり、低侵襲手術に対する有利な償還シナリオ、塞栓療法機器の技術進歩の高まりです。

低侵襲手術に対する需要の高まりは、塞栓療法市場の成長をサポートすると予想されます。塞栓療法は、がん、子宮筋腫、動脈瘤、血管奇形など、さまざまな病状を治療するために用いられる低侵襲な手法です。Statistaによると、2019年、世界の低侵襲手術市場は205億米ドルとなり、2030年には440億4,000万米ドルに達すると予測されています。その結果、低侵襲手術に対する需要の高まりが、市場の成長を促進すると予想されます。また、新興国市場の患者数の増加や、医療・ヘルスケア施設整備のための政府・民間団体による資金調達・投資の増加は、予測期間中に同市場に有利な機会をもたらすと予想されています。しかし、十分なエビデンスの欠如と不利な規制シナリオ、代替療法の強い市場ポジショニングが、2022-2029年の予測期間を通じて市場の成長を阻害しています。

世界塞栓療法市場の調査対象となる主要地域は、アジア太平洋地域、北米、欧州、中南米、その他ラテンアメリカです。北米は、主要な市場プレイヤーの存在、有利な償還政策、市場開拓のための投資の増加により、最大の市場シェアを占めています。一方、アジア太平洋地域は、医療観光の活発化、医療ネットワークの開拓、研究開発活動の活発化などの要因により、予測期間中に最も急速に成長すると予想され、アジア太平洋地域の塞栓療法市場にとって有利な成長見通しを生み出すと考えられます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国において、産業の質的・量的な側面を取り入れることを目的としています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推計・予測、2019年～2029年
    • 塞栓療法市場、地域別、2019年～2029年
    • 塞栓療法市場：製品別、2019年～2029年
    • 塞栓療法市場：処置別、2019年-2029年
    • 塞栓療法市場：疾患適応症別、2019年～2029年
    • 塞栓療法市場：エンドユーザー別、2019-2029年
  • 主な動向
  • 推計手法
  • 調査の前提条件

第2章 世界の塞栓療法市場の定義と範囲

  • 調査の目的
  • 市場の定義とスコープ
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 世界の塞栓療法市場力学

  • 塞栓療法市場のインパクト分析（2019年～2029年）
    • 市場促進要因
      • 低侵襲外科手術の需要の高まり
      • 低侵襲手術に対する有利な償還シナリオ
      • 塞栓療法デバイスの技術的進歩の高まり
    • 市場の課題
      • 十分なエビデンスの欠如と不利な規制シナリオ
      • 代替療法の強い市場ポジショニング
    • 市場機会
      • 対象患者数の増加
      • 政府機関や民間企業別資金調達と投資の増加

第4章 世界の塞栓療法市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルの未来的アプローチ（2019年～2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • トップ投資機会
  • 主要成功戦略
  • 業界専門家別展望
  • アナリストの結論・提言

第5章 リスクアセスメントCOVID-19のインパクト

  • COVID-19が業界に与える全体的な影響についてのアセスメント
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 塞栓療法の世界市場：製品別

  • 市場スナップショット
  • 塞栓療法の世界市場、製品別、実績-ポテンシャル分析
  • 塞栓療法の世界市場、製品別推定・予測2019-2029
  • 塞栓療法市場、サブセグメント別分析
    • エンボリックアージェント
    • サポートデバイス

第7章 塞栓療法の世界市場：施術別

  • 市場スナップショット
  • 塞栓療法の世界市場：施術別、実績-ポテンシャル分析
  • 塞栓療法の世界市場、施術別推定・予測2019-2029
  • 塞栓療法市場、サブセグメント別分析
    • 経カテーテル動脈塞栓術（TAE）
    • 選択的内部放射線療法（SIRT）
    • 経動脈的化学塞栓療法（TACE）

第8章 塞栓療法の世界市場、疾患適応症別

  • 市場スナップショット
  • エンボロセラピーの世界市場：疾患適応症別、実績 - ポテンシャル分析
  • 塞栓療法の世界市場、疾患適応症別推定・予測2019～2029年
  • 塞栓療法市場、サブセグメント別分析
    • がん
    • 末梢血管疾患
    • 神経系疾患
    • 泌尿器系疾患
    • 腎臓疾患
    • 消化器系疾患

第9章 塞栓療法の世界市場：エンドユーザー別

  • 市場スナップショット
  • エンボロセラピーの世界市場：エンドユーザー別実績・ポテンシャル分析
  • 塞栓療法の世界市場、エンドユーザー別推定・予測2019-2029
  • 塞栓療法市場、サブセグメント別分析
    • 病院
    • 診療所
    • 外来手術センター
    • その他

第10章 塞栓療法の世界市場：地域別分析

  • 塞栓療法の市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品別の推定・予測、2019年～2029年
      • 処置別の推定・予測、2019年～2029年
      • 疾患適応症別の推定・予測、2019年～2029年
      • エンドユーザー別の推定・予測、2019年～2029年
    • カナダ
  • 欧州の塞栓療法市場スナップショット
    • U.K.
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の塞栓療法市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのエンボロセラピー市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第11章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Imbiotechnologies Ltd.
      • 主要情報
      • 概要
      • 財務情報（データ提供可能な場合のみ）
      • 製品概要
      • 最近の開発状況
    • Johnson & Johnson
    • Kaneka Corporation
    • Medtronic Plc
    • Meril Life Sciences Pvt. Ltd.
    • Merit Medical Systems, Inc.
    • Penumbra, Inc.
    • Simbionix USA Corporation
    • Sirtex Medical Limited
    • Stryker Corporation

第12章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Embolotherapy Market, report scope
  • TABLE 2. Global Embolotherapy Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Embolotherapy Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 4. Global Embolotherapy Market estimates & forecasts by Procedure 2019-2029 (USD Billion)
  • TABLE 5. Global Embolotherapy Market estimates & forecasts by Disease indication 2019-2029 (USD Billion)
  • TABLE 6. Global Embolotherapy Market estimates & forecasts by End user 2019-2029 (USD Billion)
  • TABLE 7. Global Embolotherapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Embolotherapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Embolotherapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Embolotherapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Embolotherapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Embolotherapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Embolotherapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Embolotherapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Embolotherapy Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. Global Embolotherapy Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 18. U.S. Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. U.S. Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 21. Canada Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. Canada Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 24. UK Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. UK Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 27. Germany Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. Germany Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 30. France Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. France Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 33. Italy Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Italy Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 36. Spain Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. Spain Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 39. RoE Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. RoE Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 42. China Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. China Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 45. India Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. India Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 48. Japan Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. Japan Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 51. South Korea Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. South Korea Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 54. Australia Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. Australia Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. RoAPAC Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 60. Brazil Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Brazil Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 63. Mexico Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. Mexico Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 66. RoLA Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. RoLA Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Embolotherapy Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 69. Row Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. Row Embolotherapy Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 71. List of secondary sources, used in the study of global Embolotherapy Market
  • TABLE 72. List of primary sources, used in the study of global Embolotherapy Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Embolotherapy Market, research methodology
  • FIG 2. Global Embolotherapy Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Embolotherapy Market, key trends 2021
  • FIG 5. Global Embolotherapy Market, growth prospects 2022-2029
  • FIG 6. Global Embolotherapy Market, porters 5 force model
  • FIG 7. Global Embolotherapy Market, pest analysis
  • FIG 8. Global Embolotherapy Market, value chain analysis
  • FIG 9. Global Embolotherapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Embolotherapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Embolotherapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Embolotherapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Embolotherapy Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Embolotherapy Market, regional snapshot 2019 & 2029
  • FIG 15. North America Embolotherapy Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Embolotherapy Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Embolotherapy Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Embolotherapy Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Embolotherapy Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Embolotherapy Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Embolotherapy is a minimally invasive medical procedure that involves the use of embolic agents to block blood vessels or blood flow in order to treat a variety of medical conditions. Embolic agents can be solid particles, gels, or liquids that are injected directly into a blood vessel, causing the vessel to clot and preventing blood from flowing to a specific area of the body. Embolotherapy is used to treat a variety of conditions, including uterine fibroids, liver tumors, aneurysms, and vascular malformations. The technique is minimally invasive than traditional surgery and can be performed on an outpatient basis in some cases, with shorter recovery times and fewer complications. The key factor driving the market growth is rising demand for the minimally invasive surgical procedures, favorable reimbursement scenario for minimally invasive surgeries and growing technological advancement in embolotherapy devices.

The rising demand for minimally invasive surgical procedures is anticipated to support the growth of the embolotherapy market. Embolotherapy is a minimally invasive technique used to treat a wide range of medical conditions, including cancer, uterine fibroids, aneurysms, and vascular malformations. According to Statista, in 2019, the minimally invasive surgery market globally was valued USD 20.5 billion and it is anticipated to reach USD 44.04 billion by 2030. As a result, the rising demand for the minimally invasive surgical procedures is anticipated to propel the market growth. Additionally, the growing target patient population and rising funding & investment by government and private organizations for the medical and health care facility development is anticipated to create the lucrative opportunity for the market during projected period. However, the lack of sufficient evidence & unfavorable regulatory scenario, and strong market positioning of alternative therapies stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Embolotherapy Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominates the market holding the largest market share, owing to the presence of key market players, favorable reimbursement policies, and growing investments for the healthcare facility development. Whereas, Asia Pacific is anticipated to exhibit fastest growing region during forecasted period over the forecast period, owing to factors such as booming medical tourism, developing healthcare network and increasing research and development activities in the region would create lucrative growth prospects for the Embolotherapy market across Asia Pacific region.

Major market players included in this report are:

  • Imbiotechnologies Ltd.
  • Johnson & Johnson
  • Kaneka Corporation
  • Medtronic Plc
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Simbionix USA Corporation
  • Sirtex Medical Limited
  • Stryker Corporation

Recent Developments in the Market:

  • In 2021, Terumo Corporation has received FDA approval for the PMA Supplement for the WEB 17 System, a novel component of the WEB Aneurysm Embolisation System for the treatment of intracranial wide-neck bifurcation aneurysms.

Global Embolotherapy Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Procedure, Disease indication, End user, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Embolic Agents
  • Support Devices

By Procedure:

  • Transcatheter Arterial Embolization (TAE)
  • Selective Internal Radiation Therapy (SIRT)
  • Trans arterial Chemoembolization (TACE)

By Disease indication:

  • Cancer
  • Peripheral Vascular Disease
  • Neurological Diseases
  • Urological
  • Nephrological Disorders
  • Gastrointestinal Disorders

By End user:

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Embolotherapy Market, by region, 2019-2029 (USD Billion)
    • 1.2.2. Embolotherapy Market, by Product, 2019-2029 (USD Billion)
    • 1.2.3. Embolotherapy Market, by Procedure, 2019-2029 (USD Billion)
    • 1.2.4. Embolotherapy Market, by Disease indication, 2019-2029 (USD Billion)
    • 1.2.5. Embolotherapy Market, by End user, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Embolotherapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Embolotherapy Market Dynamics

  • 3.1. Embolotherapy Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising demand for the minimally invasive surgical procedures
      • 3.1.1.2. Favourable reimbursement scenario for minimally invasive surgeries
      • 3.1.1.3. Growing technological advancements in embolotherapy devices
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
      • 3.1.2.2. Strong market positioning of alternative therapies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing target patient populations
      • 3.1.3.2. Rising funding & investment by government and private organizations

Chapter 4. Global Embolotherapy Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Embolotherapy Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Embolotherapy Market by Product, Performance - Potential Analysis
  • 6.3. Global Embolotherapy Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 6.4. Embolotherapy Market, Sub Segment Analysis
    • 6.4.1. Embolic Agents
    • 6.4.2. Support Devices

Chapter 7. Global Embolotherapy Market, by Procedure

  • 7.1. Market Snapshot
  • 7.2. Global Embolotherapy Market by Procedure, Performance - Potential Analysis
  • 7.3. Global Embolotherapy Market Estimates & Forecasts by Procedure 2019-2029 (USD Billion)
  • 7.4. Embolotherapy Market, Sub Segment Analysis
    • 7.4.1. Transcatheter Arterial Embolization (TAE)
    • 7.4.2. Selective Internal Radiation Therapy (SIRT)
    • 7.4.3. Trans arterial Chemoembolization (TACE)

Chapter 8. Global Embolotherapy Market, by Disease indication

  • 8.1. Market Snapshot
  • 8.2. Global Embolotherapy Market by Disease indication, Performance - Potential Analysis
  • 8.3. Global Embolotherapy Market Estimates & Forecasts by Disease indication 2019-2029 (USD Billion)
  • 8.4. Embolotherapy Market, Sub Segment Analysis
    • 8.4.1. Cancer
    • 8.4.2. Peripheral Vascular Disease
    • 8.4.3. Neurological Diseases
    • 8.4.4. Urological
    • 8.4.5. Nephrological Disorders
    • 8.4.6. Gastrointestinal Disorders

Chapter 9. Global Embolotherapy Market, by End user

  • 9.1. Market Snapshot
  • 9.2. Global Embolotherapy Market by End user, Performance - Potential Analysis
  • 9.3. Global Embolotherapy Market Estimates & Forecasts by End user 2019-2029 (USD Billion)
  • 9.4. Embolotherapy Market, Sub Segment Analysis
    • 9.4.1. Hospitals
    • 9.4.2. Clinics
    • 9.4.3. Ambulatory Surgery Centers
    • 9.4.4. Others

Chapter 10. Global Embolotherapy Market, Regional Analysis

  • 10.1. Embolotherapy Market, Regional Market Snapshot
  • 10.2. North America Embolotherapy Market
    • 10.2.1. U.S. Embolotherapy Market
      • 10.2.1.1. Product breakdown estimates & forecasts, 2019-2029
      • 10.2.1.2. Procedure breakdown estimates & forecasts, 2019-2029
      • 10.2.1.3. Disease indication breakdown estimates & forecasts, 2019-2029
      • 10.2.1.4. End user breakdown estimates & forecasts, 2019-2029
    • 10.2.2. Canada Embolotherapy Market
  • 10.3. Europe Embolotherapy Market Snapshot
    • 10.3.1. U.K. Embolotherapy Market
    • 10.3.2. Germany Embolotherapy Market
    • 10.3.3. France Embolotherapy Market
    • 10.3.4. Spain Embolotherapy Market
    • 10.3.5. Italy Embolotherapy Market
    • 10.3.6. Rest of Europe Embolotherapy Market
  • 10.4. Asia-Pacific Embolotherapy Market Snapshot
    • 10.4.1. China Embolotherapy Market
    • 10.4.2. India Embolotherapy Market
    • 10.4.3. Japan Embolotherapy Market
    • 10.4.4. Australia Embolotherapy Market
    • 10.4.5. South Korea Embolotherapy Market
    • 10.4.6. Rest of Asia Pacific Embolotherapy Market
  • 10.5. Latin America Embolotherapy Market Snapshot
    • 10.5.1. Brazil Embolotherapy Market
    • 10.5.2. Mexico Embolotherapy Market
    • 10.5.3. Rest of Latin America Embolotherapy Market
  • 10.6. Rest of The World Embolotherapy Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. Imbiotechnologies Ltd.
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. Johnson & Johnson
    • 11.2.3. Kaneka Corporation
    • 11.2.4. Medtronic Plc
    • 11.2.5. Meril Life Sciences Pvt. Ltd.
    • 11.2.6. Merit Medical Systems, Inc.
    • 11.2.7. Penumbra, Inc.
    • 11.2.8. Simbionix USA Corporation
    • 11.2.9. Sirtex Medical Limited
    • 11.2.10. Stryker Corporation

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption